Conflict of interest: It is ethical for an investigator to also be the primary care-giver in a clinical trial

Journal of Neuro-Oncology

Volumn 63, Issue 2, 2003, Pages 107-108

  Bernstein, Mark ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ACADEMIC ACHIEVEMENT; ALERTNESS; BRACHYTHERAPY; CAREER; DOCTOR PATIENT RELATION; GLIOBLASTOMA; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; NOTE; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; WELFARE; WELLBEING;

BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH; PROFESSIONAL PATIENT RELATIONSHIP;

CAREGIVERS; CLINICAL TRIALS; CONFLICT OF INTEREST; ETHICS, MEDICAL; HUMAN EXPERIMENTATION; HUMANS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; RESEARCH PERSONNEL;

EID: 0038040838     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023959021758     Document Type: Note

References (21)

1. Goldner JA: Dealing with conflict of interest in biomedical research: IRB oversight as the next best solution to the abolitionist approach. J Law Med & Ethics 28: 379-404, 2000
2. Angell M: Is academic medicine for sale? NEJM 342: 1516-1518, 2000
3. Cho MK, Shohara R, Schissel A, Rennie D: Policies on faculty conflicts of interest at US universities. JAMA 284: 2203-2208, 2000
4. DeAngelis CD, Fontanarosa PB, Flanagin A: Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 286: 89-91, 2002
5. Kassirer JP: Financial conflict of interest: An unresolved ethical frontier. Am J Law & Med 27: 149-162, 2001
6. Lo B, Wolf LE, Berkeley A: Conflict of interest policies for investigators in clinical trials. NEJM 343: 1616-1620, 2000
7. Montaner JSG, O'Shaughnessy MV, Schecter MT: Industry-sponsored clinical research: A double-edged sword. Lancet 358: 1893-1895, 2001
8. Morin K, Rakatansky H, Riddick FA, Morse LJ, O'Bannon JM, Goldrich MS, Ray P, Weiss M, Sade RM, Spillman MA: Managing conflicts of interest in the conduct of clinical trials. JAMA 287: 78-84, 2002
9. Naylor CD, for the Research Committee and Clinical Study Agreements Working Group of the Toronto Academic Health Science Council. Early Toronto experience with new standards for industry-sponsored clinical research: A progress report. Can Med Ass J 166: 413-415, 2002
10. Cattorini P, Mordacci R: The physician as caregiver and researcher. Thyroidol Clin Exp 5: 73-76, 1993
11. Cox DE, Sipprelle CN: Coercion in participation as a research subject. Am Psychol 26: 726-728, 1971
12. Elks ML: Conflict of interest and the physician-researcher. J Lab Clin Med 126: 19-23, 1995
13. Engelhardt HT: Basic ethical principles in the conduct of biomedical and behavioral research involving human subjects. Tex Rep Biol Med 38: 139-168, 1979
14. Levine RJ: Clinical trials and physicians as double agents. Yale J Biol Med 65: 65-74, 1992
15. Lidz CW, Mulvey EP, Hoge SK, Kirsch BL, Monahan J, Bennett NS, Eisenberg M, Gardner W, Roth LH: Sources of coercive behaviours in psychiatric admissions. Acta Psychiatr Scand 101: 73-79, 2000
16. Peloso PM, Riley ML: Controlled clinical trials and clinical patient-care: Sometimes in conflict. Annals RCPSC 31: 372-374, 1998
17. Weijer C, Shapiro S, Fuks A, Glass KC, Skrutkowska M: Monitoring clinical research: An obligation unfulfilled. 152: 1973-1980, 1995
18. Laperriere NJ, Leung PMK, McKenzie S, Milosevic M, Wong S, Glen J, Pintilie M, Bernstein M: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radial Oncol Biol Phys 41: 1005-1011, 1998
19. Gordon VM, Sugarman J, Kass N: Toward a more comprehensive approach to protecting human subjects. The interface of data safety monitoring boards and institutional review boards in randomized clinical trials. IRB 20: 1-5, 1998
20. Menges RJ: Openness and honesty versus coercion and deception in psychological research. Am Psychol 28: 1030-1034, 1973
21. Miller FG, Rosentein DL, DeRenzo EG: Professional integrity in clinical research. JAMA 280: 1449-1454, 1998